Gefitinib or Carboplatin–Paclitaxel in Pulmonary AdenocarcinomaTony Mok, Masahiro Fukuoka, Baohui Han et al.|New England Journal of Medicine|2009Cited by 8.2k
Interstitial Lung Disease in Japanese Patients with Lung CancerShoji Kudoh, Fredrik Nyberg, Harubumi Kato et al.|American Journal of Respiratory and Critical Care Medicine|2008Cited by 488
Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung CancerRiichiroh Maruyama, Masahiro Fukuoka, Yutaka Nishiwaki et al.|Journal of Clinical Oncology|2008Cited by 365